Navigation Links
Glenmark’s new molecule to go through trial

Glenmark Pharmaceuticals Ltd today said its newly- found andti-diabetic/anti-obesity molecule will be put into clinical trials by later this year. Mr Glenn Saldanha, Executive Director, Glenmark pharmaceuticals, told newspersons that the company’s R&D team has established ‘proof of concept’ in animals for this molecule.//

The global diabetes market is estimated to be in the region of Rs. 400 crore. The company is scouting for partners to take the molecule into advanced phases of clinical trials. Mr. Saldahna said that the pre-clinical trials for the molecule are expected to be completed in the next six months and then the Phase I clinical studies will be initiated in Europe.

"We are scouting for contract research organisations (CROs) in Europe which will take the moleucle code named - GRC -1087 - through Phase I and probably Phase II A or early Phase II clinical trials. We might be in a position to announce the CRO in the next three months," Mr Saldanha said. The clinical trials will cost around $1 millin.
'"/>




Page: 1

Related medicine news :

1. Poisonous Parkinsons molecule discovered
2. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
3. Ways to counter radiation effects with new molecule discovery
4. Same molecule found in meat, milk, tumors
5. New molecule to treat brain disorders found
6. Cell molecules behind neuro degenerative diseases
7. New anti-aging molecule could be coming up in way
8. So now here might come a memory molecule!!!
9. Lost molecule holds the key to lung cancer
10. THC molecule turns out to a boon for Alzheimer’s patient
11. Sperm washing helps couples – Breakthrough in focu
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... in post-acute health care, have expanded their existing home health joint venture through ... AccentCare has been operating a joint venture home health company with Asante, delivering ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... --  Divoti USA will engrave and process all ... the latest FDA requirements, which stipulates new criteria regarding medical device ... of Medical ID jewelry such as Medical ID Bracelets, can rest ... terms of the new FDA requirements . ... Divoti offers this dark mark fiber laser engraving ...
(Date:10/11/2017)... , Oct. 11, 2017  Caris Life Sciences ® ... fulfilling the promise of precision medicine, today announced that ... Caris, Precision Oncology Alliance™ (POA) as its 17 th ... the St. Jude Crosson Cancer Institute will help develop ... use of tumor profiling, making cancer treatment more precise ...
(Date:10/10/2017)... 10, 2017  NDS received FDA 510(k) clearance in May 2017 ... display stand specifically designed for endoscopy environments. An innovative secondary monitor ... clinical solution to support the improvement of patient outcomes, procedural efficiency, ... ... ...
Breaking Medicine Technology: